Gleevec and Nephrolithiasis - from FDA reports


Summary

Nephrolithiasis is found among people who take Gleevec, especially for people who are male, 40-49 old , have been taking the drug for 1 - 6 months, also take medication Zometa, and have Chronic myeloid leukaemia . We study 24,728 people who have side effects while taking Gleevec from FDA. Among them, 116 have Nephrolithiasis. Find out below who they are, when they have Nephrolithiasis and more.

What to expect?

If you take Gleevec and have Nephrolithiasis, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Gleevec and have Nephrolithiasis

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

Gleevec

Gleevec has active ingredients of imatinib mesylate. It is often used in chronic myelogenous leukemia (cml). (latest outcomes from Gleevec 25,083 users)

Nephrolithiasis

Nephrolithiasis (calculi in the kidneys) has been reported by people with multiple sclerosis, osteoporosis, rheumatoid arthritis, high blood pressure, crohn's disease (latest reports from 23,015 Nephrolithiasis patients).

On Jan, 27, 2017

24,728 people reported to have side effects when taking Gleevec.
Among them, 116 people (0.47%) have Nephrolithiasis


Number of reports submitted per year:

Could Gleevec cause Nephrolithiasis?

Time on Gleevec when people have Nephrolithiasis *:

  • < 1 month: 22.22 %
  • 1 - 6 months: 44.44 %
  • 6 - 12 months: 11.11 %
  • 1 - 2 years: 11.11 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 11.11 %
  • 10+ years: 0.0 %

Gender of people who have Nephrolithiasis when taking Gleevec *:

  • female: 35.4 %
  • male: 64.6 %

Age of people who have Nephrolithiasis when taking Gleevec *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 5.88 %
  • 20-29: 3.92 %
  • 30-39: 9.8 %
  • 40-49: 31.37 %
  • 50-59: 19.61 %
  • 60+: 29.41 %

Top conditions involved for these people *:

  • Chronic Myeloid Leukaemia (47 people, 40.52%)
  • Osteoporosis (11 people, 9.48%)
  • Gastrointestinal Stromal Tumour (9 people, 7.76%)
  • Preventive Health Care (5 people, 4.31%)
  • Malignant Soft Tissue Neoplasm (5 people, 4.31%)

Top co-used drugs for these people *:

  • Zometa (18 people, 15.52%)
  • Rocephin (12 people, 10.34%)
  • Compazine (12 people, 10.34%)
  • Aredia (12 people, 10.34%)
  • Singulair (11 people, 9.48%)

Top other side effects for these people *:

  • Nausea (30 people, 25.86%)
  • Fatigue (27 people, 23.28%)
  • Pain (25 people, 21.55%)
  • Back Pain (23 people, 19.83%)
  • Upper Respiratory Tract Infection (22 people, 18.97%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Nephrolithiasis when taking Gleevec?

Browse all side effects of Gleevec

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Nephrolithiasis

Nephrolithiasis

Could your condition cause Nephrolithiasis

Nephrolithiasis

Related studies

Can you answer these questions?

More questions for: Gleevec, Nephrolithiasis

You may be interested in these reviews

More reviews for: Gleevec, Nephrolithiasis